Generic Drug Use In Japanese DPC Hospitals Increases To 7.4 Percent
This article was originally published in PharmAsia News
Executive SummaryGeneric drug use in Japanese hospitals using a diagnostic procedure combined payment method continue to rise, accounting for 7.4 percent in terms of total drugs dispensed in 2008, growing year-on-year from 3.4 percent in 2004.The recent survey conducted by the Ministry of Health, Labor and Welfare also found that the number of hospitals grew from 144 to 841 in five years. The ratio of drug expense out of total medical treatment fees in these hospitals has dropped from 15.8 to 12.8 percent (Click here for more - Japanese language).
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
FerGene bladder cancer therapy achieved a complete response in more than half of patients in its pivotal trial. The joint venture now looks to commercialization and potential expansion of indications.